PL425239A1 - Application of 2'-hydroxy-4-methylchalcone - Google Patents

Application of 2'-hydroxy-4-methylchalcone

Info

Publication number
PL425239A1
PL425239A1 PL425239A PL42523918A PL425239A1 PL 425239 A1 PL425239 A1 PL 425239A1 PL 425239 A PL425239 A PL 425239A PL 42523918 A PL42523918 A PL 42523918A PL 425239 A1 PL425239 A1 PL 425239A1
Authority
PL
Poland
Prior art keywords
methylchalcone
hydroxy
application
prevention
treatment
Prior art date
Application number
PL425239A
Other languages
Polish (pl)
Other versions
PL238125B1 (en
Inventor
Ewa Grela
Joanna Kozłowska
Mirosław Anioł
Agnieszka Grabowiecka
Bartłomiej Potaniec
Original Assignee
Uniwersytet Przyrodniczy we Wrocławiu
Politechnika Wrocławska
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Przyrodniczy we Wrocławiu, Politechnika Wrocławska filed Critical Uniwersytet Przyrodniczy we Wrocławiu
Priority to PL425239(22)20180416A priority Critical patent/PL238125B1/en
Publication of PL425239A1 publication Critical patent/PL425239A1/en
Publication of PL238125B1 publication Critical patent/PL238125B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Przedmiotem zgłoszenia jest zastosowanie 2'-hydroksy-4-metylochalkonu do wytwarzania leku i/lub jako składnika produktów leczniczych do leczenia i zapobiegania kamicy nerkowej, kamicy moczowodu oraz kamienia w obrębie dolnych dróg moczowych, jak również zapalenia pęcherza moczowego oraz do wytwarzania suplementów diety, środków żywieniowych lub jako składnika żywności funkcjonalnej, stosowanych wspomagająco w leczeniu i w profilaktyce tych chorób.The subject of the application is the use of 2'-hydroxy-4-methylchalcone for the manufacture of a drug and / or as a component of medicinal products for the treatment and prevention of nephrolithiasis, ureterolithiasis and calculus in the lower urinary tract, as well as cystitis and for the production of dietary supplements, nutritional agents or as an ingredient of functional foods, used to support the treatment and prevention of these diseases.

PL425239(22)20180416A 2018-04-16 2018-04-16 Application of 2'-hydroxy-4-methylchalcone PL238125B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL425239(22)20180416A PL238125B1 (en) 2018-04-16 2018-04-16 Application of 2'-hydroxy-4-methylchalcone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL425239(22)20180416A PL238125B1 (en) 2018-04-16 2018-04-16 Application of 2'-hydroxy-4-methylchalcone

Publications (2)

Publication Number Publication Date
PL425239A1 true PL425239A1 (en) 2019-10-21
PL238125B1 PL238125B1 (en) 2021-07-05

Family

ID=68238640

Family Applications (1)

Application Number Title Priority Date Filing Date
PL425239(22)20180416A PL238125B1 (en) 2018-04-16 2018-04-16 Application of 2'-hydroxy-4-methylchalcone

Country Status (1)

Country Link
PL (1) PL238125B1 (en)

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
GOODARZI M., BINARY C1ASSIFICATION OF CHALCONE DERIVATIVES WITH LDA OR KNN BASED ON THEIR ANTILEISHMANIAL ACTIVITY AND MOLECULAR DESCRIPTORS SELECTED USING THE SUCCESSIVE PROJECTIONS A1GORITHM FEATURE-SELECTION TECHNIQUE, 23 January 2014 (2014-01-23) *
M .V .KAVERI, SYNTHESIS AND SPECTRAI STUDIES OF RUCI CO L PPH3 B - HL=2-HYDROXYCHALCONES AND B = PPH3 PYRIDINE OR PIPERIDINE AND THEIR CATALYTIC AND BIOLOGICAL APPLICATIONS, 2005 *
MOSTAHAR S., CYTOTOXIC AND ANTIMICROBIAL ACTIVITIES OF SOME SYNTHETIC FLAVONES, 30 June 2006 (2006-06-30) *

Also Published As

Publication number Publication date
PL238125B1 (en) 2021-07-05

Similar Documents

Publication Publication Date Title
MA33075B1 (en) Formulated to regulate lipid metabolism
EP4553071A3 (en) Methods for improving mitophagy in subjects
BR102013003570A8 (en) PLATELET-RICH PLASMA COMPOSITIONS
BRPI0410267A (en) enzyme-containing compositions, dietetic food products and medicaments produced therefrom and their use for medical purposes
EP3318251A3 (en) Composition for preventing or treating obesity or lipid-related metabolic disease
BR112018076800A2 (en) guanidine derivative, medicament, protein 1 inhibitor of mucosal-associated lymphoid tissue lymphoma translocation, and therapeutic or prophylactic agent.
WO2019040459A3 (en) Composition and nutritional supplement made therefrom
PL425238A1 (en) Application of 2'-hydroxy-4-ethylchalcone
PL425239A1 (en) Application of 2'-hydroxy-4-methylchalcone
CO2025007626A2 (en) Pharmaceutical compositions for ocular administration
BR112019023944A2 (en) pharmaceutical combination for the treatment of cancer
PL425240A1 (en) Application of 7-aminoflavone
PL425242A1 (en) Application of 3'-amino-4-carboxychalcone
PL425241A1 (en) Application of 2'-hydroxychalcone
PL425235A1 (en) Application of isoxanthohumol
MX2007004104A (en) Use of lavender oil for the prophylaxis and treatment of neuro asthenia, somatization disorders and other diseases associated with stress.
JOP20220313A1 (en) levelimab aqueous formulation and its uses
PL423329A1 (en) Application of Kamchatka berry Lonicera caerulea L. var. Kamtschatica or its tissue or the products thereof, preferably the fruit extract
PL421363A1 (en) Application of a cornel-tree Cornus mas L. or its tissue or the products thereof, preferably fruit extract
SG11201806628UA (en) New bi-aromatic propynyl compounds, pharmaceutical and cosmetic compositions containing them and uses thereof
EP4483870A3 (en) Aqueous retinol formulations
PL414902A1 (en) Pharmaceutical composition containing combination of vitamin K1 and K2 and its application
PL445383A1 (en) Use of emodin-8-glucoside in treatment of breast cancer
PL446422A1 (en) Pharmaceutical composition supporting the immune system before and during upper respiratory tract infection
PL444627A1 (en) Pharmaceutical composition supporting the immune system before and during upper respiratory tract infection